Brief: Granules India Says Bonthapally Facility Completes US FDA Inspection
20/06/2025 12:48
June 20 (Reuters) - Granules India Ltd GRAN.NS: BONTHAPALLY FACILITY COMPLETES US FDA INSPECTION FACILITY COMPLETED FDA INSPECTION WITH ONE 483 OBSERVATION Source text: ID:nNSEbcFQWR Further company coverage: GRAN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake